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Summary: We have evaluated a fluorescence polarization immunoassay for thyroxine (T4) using the polarization
analyzer IBF-129.
Fluorescence polarization could be measured within 20 to 23 seconds after addition of fluorescein labeled thyroxine.
The method exhibited excellent specificity and acceptable accuracy. The average intra- and inter-assay coefficients of
Variation were 4.8 and 12.3%, respectively. The fluorescence polarization immunoassay was compared with a radio-
immunoassay (RIA) using 96 clinical serum samples and gave a linear regression equation: y = 0.92 + 12.5, with a
correlation coefficient of r = 0.866 (P < 0.001).
\
Prüfung eines Fluoreszenzpolarisations-Immunoassay für die Bestimmung von Thyroxin im Serum
Zusammenfassung: Wir prüften einen Fluoreszenzpolarisations-Immunoassay für Thyroxin (T4) mit dem Polarisations-
Analyser IBF-129.
Die Fluoreszenzpolarisation konnte innerhalb 20 bis 23 Sekunden nach Zugabe des Fluorescein-markierten Thyroxins
gemessen werden. Die Methode zeigte eine hervorragende Spezifität und annehmbare Richtigkeit. Die mittleren
Variationskoeffizienten betrugen 4,8% in der Serie und 12,3% von Tag zu Tag. Der Fluoreszenzpolarisations-Immuno-
assay wurde mit einem Radioimmunoassay verglichen und ergab bei Verwendung von 96 klinischen Serumproben eine
lineare Regressipnsgleichung von y = 0,92 + 12,5 mit einem Korrelationskoeffizienten von r = 0,866 (p < 0,001).
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assay (except for homogeneous enzyme immunoassay) cence polarization analyzer, IBF-1 29.
require Separation procedures for the determinatiön of
antigen or hapten in serum. The complex of antibody
and Isotope- or enzyme-labeled antigen or hapten must
be separated from the free labeled component by an Materials and Methods
appropriate method. On the other hand, a fluorescence Apparates
polarization method theoretically requires np separa-
 Fluorescence polarization was detected by a fluorescence polari-
tion procediires. The theory of the fluorescence polariza-
 zation anaiyzer (JIMCO Model IBF-129, Sanko Junyaku Co.,
tiön was developed by Perrin (6) and was extended Ltd.). This apparatus is equipped with a lamp housing (tungsten
through the work of Weber
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 52o nm, and a photomultipüer with an>amplifier system con-
cence polarization method to antigen-antibody reaction nected to a digital printer. The arbitrary polarization. Parb.» is
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presented s a multiple of around 1000 of thc real polarization,
P, defined by the equation 450-
P =
where l „and 1^  represent the emission intensities polarized
parallel and perpendicular to the direction of polarization of the
exciting light, respectively. In an antigen-antibody reaction
System, the specific antibody binds the antigen labeled with a
fluorochrome, resulting in an increase of P. Upon addition of
unlabeled antigen, bound labeled antigen will be displaced from
the antibody and P will decrease accordingly. The temperature
of the cell housing is kept constant during the measurement with
a Haake FK circulator (Haake Co., Ltd.).
Reagents
Fluorescein-labeled thyroxine, antiserum to thyroxine, Standard
thyroxine serum, and phosphate buffered saune containing
polyethylene glycol were gifts from Sanko Junyaku Co., Ltd. in
Tokyo. Methanol used for extraction of thyroxine from serum
\vas reagent grade (Wako Junyaku Co., Ltd.).
The lyophilized fluorescein-labeled thyroxine, anti-thyroxine
antibody (IgG fraction), and thyroxine Standard serum were
dissolved daily in the specified volume of distilled deiqnized
water. The nominal concentration of the Standards are 10, 50,
100, 200, and 400 Mg/1.
Procedure
Four hundred μΐ of methanol was added to 200 μΐ of Standard,
pooled or sample serum in small siliconized test tubes. This mix-
ture was vigorously stirred with a Vortex mixer and was allowed
to stand for 5 minutes. The mixture was centrifuged for 10 min-
utes at 1000 g. Fifty μΐ of the supernatant was added to 2 ml of
1/15 mol/1 phosphate buffered saune containing 25 g/l poly-
ethylene glycol, pH 7.2, and 50 μΐ antibody to thyroxine was
subsequently added. This mixture was vigorously stirred and
incubated for 60 minutes at 25 °C (unless otherwise specified).
After incubation, 50 μΐ of fluorescein-labeled thyroxine was
added, the mixture was agitated for 20 to 23 seconds and the
fluorescence polarization was immediately measured in the
IBF-129. Measurements were performed at 25 ± 0.1 °C.
Preparation ofcharcoal treated serum
For dilution of test sera or Standards, charcoal treated serum was
prepared by incubating 50 ml of pooled ser m (84 μg/l thyroxine,
RIA value) with 5 g of charcoal (Wako Junyaku Co., Ltd.) for
4 hours at room temperature. The charcoal was filtered off and
the filtrate was divided into small aliquots which were stored at
- 20 °C until use. The concentration of thyroxine of this char-
coal treated serum s determined by the radioimmunoassay was
14 ng/1.
Radioimmunoassay of thyroxine
Serum thyroxine was measured simultaneously by use of Tetra-
Tab RIA kit (Nuclear-Medical Laboratories, Inc.) in Clinical
Radiology, Asahikawa Medical College Hospital, Japan. Each
kit contains an extractant (0.025 mol/i HC1), [12*IJ thyroxine
reagent (0.185 MBq or less), anti thyroxine serum, precipitant
(ammonium sulfate), diluent (barbital buffer), and Standards
(10, 60, 120, and 180 μg/l thyroxine).
Results
Time-course o/Parb. and effect of incubation time
Figure l shows the time-course of ΡΜΐ). and the effect of
incubation time. The initial P^. obtained at 18, 113,
and 209 jug/1 thyroxine (RIA value) were around 400,
350, and 300, respectiveiy. P^ increases gradually with·
time and reaches a plateau in about 5^-6 hours (data
0 5 10
t [ m i n ]
Fig. 1. Time-course of rbitrary polarization and effect of
incubation time.
Incubation time: o, 30 min; ·, 60 min; a, 90 min;
·, 120min.
Thyroxine coneentrations: a, 18 Mg/1; b, 113 μg/l;
c, 209 μβ/1.
not shown). The assay was incubated for 30, 60, 90, and
120 minutes. As shown in figure l, the initial P^ and
the increase of Parbf were not influenced by the incuba-
tion time for each level of thyroxine.
Standard curve
The Standard curve is shown by the solid line in figure 2.
The points represent the mean value of PBj:bm and the
bars two Standard deviations. The concentration of
thyroxine in the Standard serum was measured by radio-
immunoassay. Standard sera with intermedi te levels
were prepared by dilution of the dommercially available,
high thyroxine level Standard serum with the charcoal
treated serum.
450
.§ 400
g*
l 350
300
Fig. 2.
50 100 150
Thyroxine [/ig/U
200
Standard curve and dilution curve. Solid line is the
primary Standard curve and dotted line (ά) is the dilution
curve. Broken lines are the Standard curves obtained in
2 (o) and 9 min (·). . ;
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As mentioned above, .^ increases with time, so that
the Standard curves obtained in 2 or 9 minutes are
parallel to the primary Standard curve äs shown by the
broken lines in figure 2. In this experiment the primary
Standard curve is used because the measurement is
accomplished in a short time.
As is evident from the figure 2, the measurable ränge is
from 18 to 209 %1\. For samples of serum having higher
than 209 g/l of thyroxine, dilution of the serum is
required. The high thyroxine level serum was diluted with
the charcoal treated serum and, äs shown by the dotted
line in figure 2, the dilution curve was parallel to the
Standard curve.
Specificity ofthe method
The specificity of the thyroxine antibody was examined
by determining the cross reactivity of triiodothyronine
(3,5,3'-triiodothyronine, T3) with the thyroxine anti-
body (fig. 3). In these experiments triiodothyronine or
thyroxine dissolved in methanol was used. When the
concentration of thyroxine was 8 /ig/1, Parb was 322,
and the same value was obtained at 1000 ^ g/1 triiodo-
thyronine; indicating that the degree of cross reactivity
is only 0.8% at this concentration.
350
.300
250
Tab. 1. Intra- and inter-assay reproducibility of three thyroxine
, levels in sera.
0.1 10 100
Thyroid hormone [/ig/l]
1000
Fig. 3. Cross reactivity of triiodothyronine with thyroxine
antibody.
o, thyroxine; ·, triiodothyronine.
Precision ofthe method
The intra- and inter-assay reproducibility of the method
was determined from the measurements of thyroxine
concentration in pooled senim ät thfee thyrpxine levels.
Ten determinations were made on the same day for
each of the three pooled sera and the intra-assay mean
thyroxine values for the low, intermediäte, and high
level pools are shown in table 1. The average intra-assay
coefficient of Variation was 4.8%. Six determinations
were made on separate days and the inter-assay mean
thyroxine values for the low, intermediäte, and high
levei pools are also shown in table l. The average inter-
assay coefficient of Variation was 12.3%.
Intra-assay
(n = 10)
Inter-assay
(n =6)
Thyroxine
levels
•Low
Intermediate
High
Low
Intermediate
High
Mean
(Mg/D
34
85
174
36
76
178
S.D.*
(Mg/1)
2.2
4.8
4.7
4.5
9.6
21
C.V.**
(%)
6.0
5.6
2.7
12.4
12.6
12.0
* S, D.: Standard deviation
** C.V.: coefficient of Variation
Accuracy ofthe method
The accuracy of the method was examined through
recovery studies, where the recovery of thyroxine added
to charcoal treated serum was determined. The final
concentration of added thyroxine was 106 g/l and the
average recovery for thyroxine was 104.5% (ränge:
95.2-109.4%, n = 5).
Correlation offhethods
Serum thyroxine values obtained from the fluorescence
polarization method were compared with those obtained
by radioimmunoassay. In figure 4, the correlation be-
tween the two methods and the least squares line are
shown. The correlation coefficient (r) is 0.866. The
regression line is calculated äs y = 0.92 + 12.5, y being
the value obtained by fluorescence polarization method.
Twenty sera from the healthy students were analyzed.
Thyroxine values (59~99 Mg/1) of these samples were in
the normal ränge (45~115 /ig/l) established for the radio-
immunoassay of thyroxine (Tetra-Tab RIA kit).
5300
•f 200
o
s
!10Q
100 200
Thyroxine (rodioimmunoossay) t/ig/ll
300
Fig. 4. Correlation between thyroxine values äs measured by
fluorescence polarization immunoassay and radio-
immunoassay.
y = 0.92 + 12.5; r = 0.866 (p < 0.001), n = 96.
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Discussion
We evaluated the fluorescence polarization immunoassay
for semm thyroxine level using the IBF-129.
Parb values were not influenced by the incubation time,
so that it is convenient fpr a large number of samples to
be assayed at the same time. Thyroxine concentration
was determined with a known amount of anti-thyroxine
antibody, which first reacted with an unknown amount
of thyroxine in samples, followed by addition of a defi-
nite amount of the fluorescein-labeled thyroxine. After
addition of the labeled thyroxine, P^b. was measured
within 20 to 23 seconds, so that thyroxine content can
be determined in a short time.
It may be concluded that specificity of the method was
excellent (the degree of cross reactivity with triiodo-
thyronine was 0.8% at a thyroxine concentration of
8 g/l). Triiodothyronine concentration in serum is less
than 0.2% of the thyroxine concentration, so that the
presence of triiodothyronine will not affect the assay in
practice.
The average recovery of thyroxine added to the charcoal
treated serum was 104.5%, documenting the accuracy of
the method.
Precision studies resulted in average intra- and inter-assay
coefficients of Variation for thyroxine of 4.8 and 12.3%,
respectively. The reproducibility was slightly inferior
to that of the radioimmunoassay (Tetra-Tab RIA kit)
used in the experiment (average intra- and inter-assay
coefficients of Variation of 3.6 and 6.7%, respectively).
These values are acceptable at present, äs it was reported
that the average intra- and inter-assay coefficients of
Variation for cortisol obtained with use of IBF-129 were
14.3 and 17.1%, respectively (13).
The method was compared with the radioimmunoassay.
A correlation coefficient of 0.866 between the two
methods was poor. We therefore determined the coeffl·
cient of determination, r2. This was 0.750, which indi-
cates that the proportion of the Variation in the fluores-
cence polarization immunoassay associated with the
Variation in the iadioimmunoassay is 75%. Twenty five
percent of the Variation may be relateü tp the inferior
reproducibility pf the fluorescence polarization immuno-
assay which is acceptafole at present, äs before. The
fluorescence polarization immunoassay, however, does
not require Separation of anti-thyroxine antibody bound
and free thyroxine äs compared with radioimmunoassay.
The method is non-dsotopic and, therefore, can be
performed in a usual labpratory without radiatipn
hazards.
The fluorescence polarization immunoassay may be a
more convenient technique for routine work, if the
automation of the assay procedure is developed. At
pfesent, the assay for thyroxine reqüires the extraction
procedure, so that automation is difficult. In the light
of this problem, it is interesting to note that a direct
assay System for cortisol has been developed by applyimg
pretreätment öf serum with sodium dodecyl sulfate
which decomposes serum proteins (14). In the assay of
thyroxine, however, the treatment with sodium dodecyl
sulfate gave often abnormal high .^ values. Therefore,
a different treatment must be found äs a prelirninary tp
automation; this is the subject of a future study. Further
modification of the IBF-129 will be reqüired for automa-
tion.
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